Medicine and Dentistry
Combination Therapy
9%
Disease Exacerbation
9%
Diseases
18%
Enalapril Maleate
18%
Experience
100%
Hepatocellular Carcinoma
36%
Histopathology
9%
Inpatient
9%
Liver
9%
Liver Transplantation
100%
Log Rank Test
9%
Mortality
18%
Necrosis
9%
Neoadjuvant Therapy
9%
Organ
18%
Overall Survival
36%
Patient
100%
Proportional Hazards Model
9%
Radioembolization
100%
Recurrence Free Survival
45%
Recurrent Disease
18%
Survival Rate
9%
Therapeutic Procedure
9%
Toxicity
9%
Tumor Necrosis
18%
Yttrium 90
100%
Nursing and Health Professions
Combination Therapy
9%
Disease Exacerbation
9%
Diseases
18%
Enalapril Maleate
18%
Explant
9%
Liver Cell Carcinoma
36%
Liver Transplantation
100%
Log Rank Test
9%
Mortality
18%
Necrosis
9%
Neoadjuvant Therapy
9%
Overall Survival
36%
Proportional Hazards Model
9%
Radioembolization
100%
Recurrence Free Survival
45%
Recurrent Disease
18%
Staging
9%
Survival Rate
9%
Time
27%
Toxicity
9%
Tumor Necrosis
18%
Vascular Guide Wire
9%
Yttrium 90
100%
INIS
data
8%
diseases
25%
hazards
8%
hepatomas
33%
liver
100%
mortality
16%
multivariate analysis
8%
necrosis
25%
organs
16%
patients
100%
radioembolization
100%
therapy
8%
toxicity
8%
tumors
16%
yttrium 90
100%